VT
BMY icon

Vise Technologies’s Bristol-Myers Squibb BMY Stock Holding History

Vise Technologies’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.89M Hold
72,138
– – 0.08% 213
2025
Q4 		$3.89M Buy
72,138
+18,547
+35% +$892K 0.08% 214
2025
Q3 		$2.42M Sell
53,591
-22,861
-30% -$1.07M 0.09% 216
2025
Q2 		$3.54M Buy
+76,452
New +$3.75M 0.15% 157
2024
Q4 		$2.54M Buy
44,870
+11,615
+35% +$649K 0.21% 99
2024
Q3 		$1.72M Sell
33,255
-512
-2% -$24K 0.22% 98
2024
Q2 		$1.4M Sell
33,767
-5,410
-14% -$242K 0.25% 91
2024
Q1 		$2.12M Buy
39,177
+6,066
+18% +$309K 0.42% 57
2023
Q4 		$1.7M Buy
33,111
+6,541
+25% +$343K 0.37% 68
2023
Q3 		$1.54M Buy
26,570
+963
+4% +$59K 0.38% 70
2023
Q2 		$1.64M Sell
25,607
-1,489
-5% -$99.8K 0.4% 58
2023
Q1 		$1.88M Buy
27,096
+5,724
+27% +$404K 0.49% 45
2022
Q4 		$1.54M Buy
21,372
+4,173
+24% +$315K 0.48% 46
2022
Q3 		$1.22M Buy
17,199
+316
+2% +$22.9K 0.46% 44
2022
Q2 		$1.3M Buy
16,883
+7,463
+79% +$568K 0.5% 47
2022
Q1 		$688K Buy
+9,420
New +$632K 0.26% 95

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vise Technologies's BMY Position: Q1 2026 in Review

Vise Technologies held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 72,138 shares worth $3.89M. The position accounts for 0.08% of the portfolio, ranked #213.

Vise Technologies first reported a position in BMY in Q1 2022 and has held it in 16 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Vise Technologies held 72,138 shares of Bristol-Myers Squibb worth $3.89M as of Q1 2026.
  • Vise Technologies left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.08% of Vise Technologies's portfolio in Q1 2026, its #213 holding.
  • Vise Technologies first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 16 quarters since.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.